•     Home
  • About Us
    • Contact Us
    • Overview
    • Organization
    • Progress Report
    • State of the Science Symposium
  • Protocols
    • Protocols
    • Affiliate Center Application
    • New Study Form
    • Bidders
  • Links
    • BMT CTN SharePoint
    • BMT CTN AdvantageEDC
    • NHLBI Resources
      • NHLBI Website
      • National MDS Study
      • PACT (cellular)
      • GTRP (vectors)
      • SMARTT (biologics)
    • NCI
    • NMDP Patient Info
    • CIBMTR Resources
      • CIBMTR Website
      • Study Summaries for Patients
    • CTSU
    • Jason Carter Clinical Trials Program
    • Clinical Trials.gov
    • NCI IRB Page
    • Emmes
  • Resources
    • Manual of Procedures
    • Definitions
    • Video Clips
    • IFI Cost Calculator
  • Research Material
    • Biospecimen Collections
    • Data for Secondary Analyses
    • Case Report Forms
  •     Reports

  • BMT CTN Funding Opportunity & RFI


      RO1: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)
  • BMT CTN Publications


      Publications

      Patient Level Summaries
  • BMT CTN News


      Core Clinical Centers/Consortia of the BMT CTN for July 2017 - June 2024

      Newly Added Protocols  

      BMTCTN 2101

      BMTCTN 2001

      BMTCTN 1905

      BMTCTN 1904

      BMTCTN 1903

      BMTCTN 1902

Definitions

Below are definitions used on BMT CTN trials:

  • Definitions of Chronic Graft-vs.-Host Disease (GVHD)
  • Severity Grading Table and Recurrence Interval Definitions
  • Definitions of Infection Severity
  • Common Terminology Criteria for Adverse Events (CTCAE) v4.0
  • Common Terminology Criteria for Adverse Events (CTCAE) v5.0
  • Social Media

 

This Project has been funded in whole or in part with Federal funds from the NHLBI, NIH, and NCI under Grant No. U01-HL069294